Copyright
©2011 Baishideng Publishing Group Co.
World J Gastroenterol. Jan 7, 2011; 17(1): 79-88
Published online Jan 7, 2011. doi: 10.3748/wjg.v17.i1.79
Published online Jan 7, 2011. doi: 10.3748/wjg.v17.i1.79
Figure 5 miR-143 and miR-145 inhibited esophageal squamous cell carcinoma cell mobility.
A: The expression levels of miR-143 and miR-145 in esophageal squamous cell carcinoma (ESCC) cell lines. Using normal tissue as the control, both miRNAs were significantly downregulated in ESCC cell lines; B: The increased expression of miR-143 and miR-145 following stable transfection. Quantitative reverse transcription-polymerase chain reaction demonstrated a significant increase in the expression levels of miR-143 and miR-145 in KYSE150 and KYSE180 cells transfected with the respective expression plasmids compared with the levels in control cells (bP < 0.01); C, D: The increased expression of miR-143 and miR-145 inhibited the mobility of both KYSE150 and KYSE180 cells. The miRNA stably transfected cells were seeded in a 6-well plate, streaks were made using a tip when the cells were grown to almost confluence 24 h later. Streaks were photographed at different intervals at 50 ×. This showed that upregulation of miR-143 and miR-145 can prevent ESCC cell wound healing. These findings are shown in (C) and (D).
- Citation: Wu BL, Xu LY, Du ZP, Liao LD, Zhang HF, Huang Q, Fang GQ, Li EM. MiRNA profile in esophageal squamous cell carcinoma: Downregulation of miR-143 and miR-145. World J Gastroenterol 2011; 17(1): 79-88
- URL: https://www.wjgnet.com/1007-9327/full/v17/i1/79.htm
- DOI: https://dx.doi.org/10.3748/wjg.v17.i1.79